The coexistence of type 1 diabetes, MODY2 and metabolic syndrome in a young girl

Acta Diabetologica

Volumn 49, Issue 5, 2012, Pages 401-404

  Calcaterra, Valeria ^a   Martinetti, Miryam ^b   Salina, Alessandro ^c   Aloi, Concetta ^c   Larizza, Daniela ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Metabolic syndrome; MODY2; Type 1 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN GLULISINE; METFORMIN; ORAL ANTIDIABETIC AGENT; THYROID ANTIBODY;

ABNORMAL LABORATORY RESULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE THYROIDITIS; CASE REPORT; CHILD; CLINICAL FEATURE; COMORBIDITY; DIET THERAPY; EXERCISE; EXON; FAMILY HISTORY; FATTY LIVER; FEMALE; FOLLOW UP; GENE MUTATION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULINEMIA; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT OUTCOME; URINALYSIS; WEIGHT GAIN;

CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOKINASE; HLA-A ANTIGENS; HUMANS; MUTATION;

EID: 84867957303     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0300-2     Document Type: Article

References (11)

1. Murphy R, Ellard S, Hattersley AT (2008) Clinical implications of molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract Endocrinol Metab 4:200-213
2. Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellanné-Chantelot C, Ellard S, Gloyn AL (2009) Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic Hypoglycemia. Hum Mutat 30:1512-1526
3. Borowiec M, Mysliwiec M, Fendler W, Antosik K, Brandt A et al (2011) Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene. Acta Diabetol Mar 25 [Epub ahead of print]
4. Umpaichitra V, Banerp MA, Castells S (2002) Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 15(suppl 1):105-109
5. Wilkin TJ (2001) The accelerator hypothesis: weight gain as the missing link between type 1 and type 2 diabetes. Diabetologia 44:914-922
6. Lorini R (1996) Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents. Diabetologia 39:370-371
7. Massa O, Meschi F, Cuesta-Munoz A, Caumo A, Cerutti F et al (2001) High prevalence of glucokinase mutations in Italian children with MODY: influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI: diabetes study group of the italian society of pediatric endocrinology and diabetology (SIEDP). Diabetologia 44:783-787
8. Pozzilli P, Buzzetti R (2007) A new expression of diabetes: double diabetes. Trend Endocrinol Metab 18:52-57
9. Otabe S, Nakayama H, Fukutani T, Yuan X, Wada N et al (2010) Excessive maternal transmission of diabetes in Japanese families with young-onset type 2 diabetes and insulin secretion defect according to clinical features. Acta Diabetol 47:133-138
10. Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW, On behalf of the DPV-Wiss Initiative of the German working group for paediatric diabetology, the german competence network diabetes mellitus (2009) Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med 26:466-473
11. Bowden SA, Hoffman RP (2008) Triple diabetes: coexistence of type 1 diabetes mellitus and a novel mutation in the gene responsible for MODY3 in an overweight adolescent. Pediatr Diabetes 9:162-164